Z. Gechtman

Synthetic peptides derived from the sequence around the plasmin cleavage site in vitronectin

S. Shaltiel, M. Fridkin, M. Fridkin, 1993, FEBS letters.

Potential involvement of BMP receptor type IB activation in a synergistic effect of chondrogenic promotion between rhTGFβ3 and rhGDF5 or rhBMP7 in human mesenchymal stem cells

L. Jolliffe, F. Farrell, L. Higgins, 2006, Growth factors.

Phosphorylation of Vitronectin by Casein Kinase II

S. Shaltiel, D. Seger, Z. Gechtman, 1998, The Journal of Biological Chemistry.

Phosphorylation of vitronectin on Ser362 by protein kinase C attenuates its cleavage by plasmin.

S. Shaltiel, Z. Gechtman, 1997, European journal of biochemistry.

The PKA phosphorylation of vitronectin: effect on conformation and function.

S. Shaltiel, V. Brumfeld, D. Seger, 2002, Archives of biochemistry and biophysics.

Neuropilin-1 Binds Vascular Endothelial Growth Factor 165, Placenta Growth Factor-2, and Heparin via Its b1b2 Domain*

Nijole Gasiunas, M. Klagsbrun, R. Mamluk, 2002, The Journal of Biological Chemistry.

The cluster of basic amino acids in vitronectin contributes to its binding of plasminogen activator inhibitor-1: evidence from thrombin-, elastase- and plasmin-cleaved vitronectins and anti-peptide antibodies.

S. Shaltiel, Z. Gechtman, A. Belleli, 1997, The Biochemical journal.

Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor: In vivo expression and antitumor activity.

S. Soker, M. Klagsbrun, S. Takashima, 2000, Proceedings of the National Academy of Sciences of the United States of America.

The Shedding of Membrane-anchored Heparin-binding Epidermal-like Growth Factor Is Regulated by the Raf/Mitogen-activated Protein Kinase Cascade and by Cell Adhesion and Spreading*

D. Ingber, M. Klagsbrun, J. Alonso, 1999, The Journal of Biological Chemistry.

Recombinant epoetins do not stimulate tumor growth in erythropoietin receptor–positive breast carcinoma models

F. Farrell, K. Lamontagne, D. Marshall, 2006, Molecular Cancer Therapeutics.